BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12925151)

  • 1. The protective effect of rebamipide on paracellular permeability of rat gastric epithelial cells.
    Joh T; Takezono Y; Oshima T; Sasaki M; Seno K; Yokoyama Y; Ohara H; Nomura T; Alexander JS; Itoh M
    Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():133-8. PubMed ID: 12925151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of cyclooxygenase-2 in rat gastric mucosa by rebamipide, a mucoprotective agent.
    Sun WH; Tsuji S; Tsujii M; Gunawan ES; Kawai N; Kimura A; Kakiuchi Y; Yasumaru M; Iijima H; Okuda Y; Sasaki Y; Hori M; Kawano S
    J Pharmacol Exp Ther; 2000 Nov; 295(2):447-52. PubMed ID: 11046075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of rebamipide on prostaglandin EP4 receptor gene expression in rat gastric mucosa.
    Suetsugu H; Ishihara S; Moriyama N; Kazumori H; Adachi K; Fukuda R; Watanabe M; Kinoshita Y
    J Lab Clin Med; 2000 Jul; 136(1):50-7. PubMed ID: 10882227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of prostaglandins in maintaining gastric mucus-cell permeability against acid exposure.
    Takezono Y; Joh T; Oshima T; Suzuki H; Seno K; Yokoyama Y; Alexander JS; Itoh M
    J Lab Clin Med; 2004 Jan; 143(1):52-8. PubMed ID: 14749685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of rebamipide on mucus secretion by endogenous prostaglandin-independent mechanism in rat gastric mucosa.
    Ishihara K; Komuro Y; Nishiyama N; Yamasaki K; Hotta K
    Arzneimittelforschung; 1992 Dec; 42(12):1462-6. PubMed ID: 1337697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rebamipide attenuates nonsteroidal anti-inflammatory drugs (NSAID) induced lipid peroxidation by the manganese superoxide dismutase (MnSOD) overexpression in gastrointestinal epithelial cells.
    Nagano Y; Matsui H; Shimokawa O; Hirayama A; Tamura M; Nakamura Y; Kaneko T; Rai K; Indo HP; Majima HJ; Hyodo I
    J Physiol Pharmacol; 2012 Apr; 63(2):137-42. PubMed ID: 22653900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rebamipide significantly inhibits indomethacin-induced mitochondrial damage, lipid peroxidation, and apoptosis in gastric epithelial RGM-1 cells.
    Nagano Y; Matsui H; Muramatsu M; Shimokawa O; Shibahara T; Yanaka A; Nakahara A; Matsuzaki Y; Tanaka N; Nakamura Y
    Dig Dis Sci; 2005 Oct; 50 Suppl 1():S76-83. PubMed ID: 16184425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of rebamipide on lipid peroxidation and gastric mucosal injury induced by indometacin in rats.
    Yoshikawa T; Naito Y; Nakamura S; Nishimura S; Kaneko T; Iinuma S; Takahashi S; Kondo M; Yamasaki K
    Arzneimittelforschung; 1993 Dec; 43(12):1327-30. PubMed ID: 8141822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of rebamipide against celecoxib-induced gastric mucosal cell apoptosis.
    Ishihara T; Tanaka K; Tashiro S; Yoshida K; Mizushima T
    Biochem Pharmacol; 2010 Jun; 79(11):1622-33. PubMed ID: 20132796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rebamipide induces the gastric mucosal protective factor, cyclooxygenase-2, via activation of 5'-AMP-activated protein kinase.
    Lee S; Jeong S; Kim W; Kim D; Yang Y; Yoon JH; Kim BJ; Min DS; Jung Y
    Biochem Biophys Res Commun; 2017 Jan; 483(1):449-455. PubMed ID: 28011266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of rebamipide against ammonia-induced gastric mucosal lesions.
    Takaishi O; Arakawa T; Yamasaki K; Fujiwara Y; Uchida T; Tominaga K; Watanabe T; Higuchi K; Fukuda T; Kobayashi K; Kuroki T
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):78S-82S. PubMed ID: 9753231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic effect of rebamipide on aspirin-induced gastric lesions and disruption of tight junctional protein zonula occludens-1 distribution.
    Suzuki T; Yoshida N; Nakabe N; Isozaki Y; Kajikawa H; Takagi T; Handa O; Kokura S; Ichikawa H; Naito Y; Matsui H; Yoshikawa T
    J Pharmacol Sci; 2008 Mar; 106(3):469-77. PubMed ID: 18360096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rebamipide reduces indomethacin-induced gastric injury in mice via down-regulation of ICAM-1 expression.
    Hiratsuka T; Futagami S; Shindo T; Hamamoto T; Ueki N; Suzuki K; Shinji Y; Kusunoki M; Shinoki K; Wada K; Miyake K; Gudis K; Tsukui T; Sakamoto C
    Dig Dis Sci; 2005 Oct; 50 Suppl 1():S84-9. PubMed ID: 16184426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of rebamipide on acetic acid-induced gastric ulcer in rats: involvement of hepatocyte growth factor.
    Udagawa A; Shiota G; Ichiba M; Murawaki Y
    Scand J Gastroenterol; 2003 Feb; 38(2):141-6. PubMed ID: 12678329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of prostaglandin biosynthesis mediates gastroprotective effect of rebamipide in rats.
    Kleine A; Kluge S; Peskar BM
    Dig Dis Sci; 1993 Aug; 38(8):1441-9. PubMed ID: 8393757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastro-protective agent rebamipide induces cyclooxygenease-2 (COX-2) in gastric epithelial cells.
    Murata H; Yabe Y; Tsuji S; Tsujii M; Fu HY; Asahi K; Eguchi H; Kawano S; Hayashi N
    Dig Dis Sci; 2005 Oct; 50 Suppl 1():S70-5. PubMed ID: 16184424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric restitution is inhibited by dexamethasone, which is reversed by hepatocyte growth factor and rebamipide.
    Takahashi M; Takada H; Takagi K; Kataoka S; Soma R; Kuwayama H
    Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():126-32. PubMed ID: 12925150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
    Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
    Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rebamipide, a gastro-protective drug, inhibits indomethacin-induced apoptosis in cultured rat gastric mucosal cells: association with the inhibition of growth arrest and DNA damage-induced 45 alpha expression.
    Naito Y; Kajikawa H; Mizushima K; Shimozawa M; Kuroda M; Katada K; Takagi T; Handa O; Kokura S; Ichikawa H; Yoshida N; Matsui H; Yoshikawa T
    Dig Dis Sci; 2005 Oct; 50 Suppl 1():S104-12. PubMed ID: 16184411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rebamipide attenuates indomethacin-induced gastric mucosal lesion formation by inhibiting activation of leukocytes in rats.
    Murakami K; Okajima K; Uchiba M; Harada N; Johno M; Okabe H; Takatsuki K
    Dig Dis Sci; 1997 Feb; 42(2):319-25. PubMed ID: 9052513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.